Clinical studyClinical deterioration in patients with idiopathic pulmonary fibrosis: Causes and assessment☆
References (75)
Idiopathic pulmonary fibrosis
- et al.
Idiopathic pulmonary fibrosis: clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects
Ann Intern Med
(1976) - et al.
Prognosis of cryptogenic fibrosing alveolitis
Thorax
(1983) Pulmonary heart disease: relation of pulmonary hypertension to abnormal lung structure and function
Bull NY Acad Med
(1977)Clinical aspects of idiopathic pulmonary fibrosis
- et al.
Cryptogenic fibrosing alveolitis and lung cancer
Thorax
(1980) Alveolar cell carcinoma occurring in idiopathic interstitial pulmonary fibrosis
Br J Dis Chest
(1970)- et al.
Simultaneous occurrence of pulmonary interstitial fibrosis and alveolar cell carcinoma in one family
Thorax
(1981) - et al.
Hypercoagulability of the blood associated with ACTH and cortisone therapy
Am J Med
(1950) Effect of prednisolone on the coagulation and fibrinolytic systems
Scand J Haematol
(1970)
Interstitial pulmonary fibrosis: clinical features, natural history, and complications
Semin Respir Med
(1984)
Desquamative interstitial pneumonia: relationship to interstitial fibrosis
Thorax
(1973)
Bronchoalveolar lavage in the diagnosis of diffuse pulmonary infiltrates in the immunosuppressed host
Ann Intern Med
(1984)
Radiographic-physiologic-pathologic correlations in interstitial pneumonias
Prog Respir Res
(1975)
Idiopathic pulmonary fibrosis: pretreatment bronchoalveolar lavage cellular constituents and their relationships with lung histopathology and clinical response to therapy
Am Rev Respir Dis
(1987)
Gallium-67 citrate scanning in the staging of idiopathic pulmonary fibrosis: correlation with physiologic and morphologic features and bronchoalveolar lavage
Am Rev Respir Dis
(1978)
Antibodies in some chronic fibrosing lung diseases I. Non organ-specific autoantibodies
Clin Allergy
(1971)
Measures of the inflammatory response in cryptogenic fibrosing alveolitis
Am Rev Respir Dis
(1988)
Interstitial lung diseases of unknown cause
et al.Interstitial lung diseases of unknown cause
Idiopathic pulmonary fibrosis
Interstitial lung disease: current concepts of pathogenesis, staging and therapy
Am J Med
(1981)
Natural and treated course of usual and desquamative interstitial pneumonia
N Engl J Med
(1978)
Diffuse interstitial pulmonary fibrosis: a clinical, radiological, and pathological study based on 45 patients
Q J Med
(1964)
Cryptogenic fibrosing alveolitis: clinical features and their influence on survival
Thorax
(1980)
The prognosis of cryptogenic fibrosing alveolitis
Thorax
(1972)
Diffuse interstitial pneumonitis: clinicopathologic correlations in 20 patients treated with prednisone/azathioprine
Am J Med
(1978)
Cryptogenic fibrosing alveolitis: assessment by graded trephine lung biopsy histology compared with clinical, radiographic, and physiological features
Br J Dis Chest
(1981)
Pulmonary hypertension in the interstitial lung diseases
Chest
(1985)
Correlative studies of pulmonary hypertension in idiopathic pulmonary fibrosis
Am Rev Respir Dis
(1977)
Idiopathic pulmonary fibrosis
Arch Intern Med
(1981)
Cardiovascular function in cor pulmonale
Another presentation of fibrosing alveolitis and alveolar cell carcinoma
Chest
(1976)
Idiopathic diffuse interstitial pulmonary fibrosis (fibrosing alveolitis), atypical epithelial proliferation and lung cancer
Am J Med
(1968)
Thromboembolic complications associated with ACTH and cortisone therapy
JAMA
(1951)
Distribution of ventilation-perfusion ratios in patients with interstitial lung disease
Chest
(1976)
Glucocorticosteroid therapy: mechanisms of action and clinical considerations
Ann Intern Med
(1976)
Increased incidence of pulmonary tuberculosis in chronic interstitial lung disease
Thorax
(1989)
Cited by (327)
Development and characterization of nintedanib inhalable powders as a potential pulmonary fibrosis treatment
2024, Journal of Drug Delivery Science and TechnologyChronic diffuse lung diseases
2022, Practical Pulmonary Pathology: A Diagnostic ApproachRethinking Idiopathic Pulmonary Fibrosis
2021, Clinics in Chest MedicineIdiopathic Pulmonary Fibrosis: A Review of Disease, Pharmacological, and Nonpharmacological Strategies With a Focus on Symptoms, Function, and Health-Related Quality of Life
2020, Journal of Pain and Symptom ManagementClinical and radiological features of pulmonary tuberculosis in patients with idiopathic pulmonary fibrosis
2019, Respiratory Investigation
- ☆
This work was supported in part by SCOR Grant HL27353 and Training Grant HL07085, National Heart, Lung and Blood Institute.
Copyright © 1990 Published by Excerpta Medica Inc.